02/01/2018 |
DOLOPHINE HYDROCHLORIDE NDA #006134 |
SUPPL-45 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/01/2018 |
METHADONE HYDROCHLORIDE NDA #006383 |
SUPPL-18 |
METHADONE HYDROCHLORIDE |
MALLINCKRODT INC |
Labeling |
Approval |
02/01/2018 |
METHADONE HYDROCHLORIDE NDA #017058 |
SUPPL-25 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/01/2018 |
METHADOSE NDA #017116 |
SUPPL-32 |
METHADONE HYDROCHLORIDE |
SPECGX LLC |
Labeling |
Approval |
02/01/2018 |
SEPTRA NDA #017376 |
SUPPL-61 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
MONARCH PHARMS |
Labeling |
Approval |
02/01/2018 |
SEPTRA DS NDA #017376 |
SUPPL-61 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
MONARCH PHARMS |
Labeling |
Approval |
02/01/2018 |
SUBUTEX NDA #020732 |
SUPPL-18 |
BUPRENORPHINE HYDROCHLORIDE |
INDIVIOR |
Labeling |
Approval |
02/01/2018 |
SUBOXONE NDA #020733 |
SUPPL-22 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
INDIVIOR |
Labeling |
Approval |
02/01/2018 |
MICARDIS NDA #020850 |
SUPPL-40 |
TELMISARTAN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
02/01/2018 |
ZYVOX NDA #021130 |
SUPPL-37 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
02/01/2018 |
ZYVOX NDA #021131 |
SUPPL-30 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
02/01/2018 |
ZYVOX NDA #021132 |
SUPPL-35 |
LINEZOLID |
PFIZER |
Labeling |
Approval |
02/01/2018 |
MICARDIS HCT NDA #021162 |
SUPPL-40 |
HYDROCHLOROTHIAZIDE; TELMISARTAN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
02/01/2018 |
SPIRIVA NDA #021395 |
SUPPL-48 |
TIOTROPIUM BROMIDE |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
02/01/2018 |
REVATIO NDA #021845 |
SUPPL-18 |
SILDENAFIL CITRATE |
VIATRIS |
Labeling |
Approval |
02/01/2018 |
TWYNSTA NDA #022401 |
SUPPL-19 |
AMLODIPINE BESYLATE; TELMISARTAN |
BOEHRINGER INGELHEIM |
Labeling |
Approval |
02/01/2018 |
SUBOXONE NDA #022410 |
SUPPL-31 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
INDIVIOR |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #078633 |
SUPPL-15 |
BUPRENORPHINE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/01/2018 |
METHADONE HYDROCHLORIDE ANDA #087393 |
SUPPL-45 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/01/2018 |
METHADONE HYDROCHLORIDE ANDA #087997 |
SUPPL-37 |
METHADONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #090279 |
SUPPL-8 |
BUPRENORPHINE HYDROCHLORIDE |
RUBICON |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #090360 |
SUPPL-15 |
BUPRENORPHINE HYDROCHLORIDE |
BARR |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #090622 |
SUPPL-25 |
BUPRENORPHINE HYDROCHLORIDE |
ETHYPHARM |
Labeling |
Approval |
02/01/2018 |
METHADONE HYDROCHLORIDE ANDA #090707 |
SUPPL-16 |
METHADONE HYDROCHLORIDE |
VISTAPHARM LLC |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #090819 |
SUPPL-12 |
BUPRENORPHINE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #091149 |
SUPPL-11 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
TEVA PHARMS USA |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #091149 |
SUPPL-12 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
TEVA PHARMS USA |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #091422 |
SUPPL-24 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ACTAVIS ELIZABETH |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #201066 |
SUPPL-8 |
BUPRENORPHINE HYDROCHLORIDE |
MYLAN |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #201633 |
SUPPL-4 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #201760 |
SUPPL-8 |
BUPRENORPHINE HYDROCHLORIDE |
SUN PHARM |
Labeling |
Approval |
02/01/2018 |
EDURANT NDA #202022 |
SUPPL-11 |
RILPIVIRINE HYDROCHLORIDE |
JANSSEN PRODS |
Efficacy |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #203136 |
SUPPL-16 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
AMNEAL PHARMS |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #203136 |
SUPPL-17 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
AMNEAL PHARMS |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #203326 |
SUPPL-10 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
HIKMA |
Labeling |
Approval |
02/01/2018 |
ZUBSOLV NDA #204242 |
SUPPL-14 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
OREXO US INC |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #204431 |
SUPPL-13 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
ETHYPHARM USA CORP |
Labeling |
Approval |
02/01/2018 |
PROBUPHINE NDA #204442 |
SUPPL-6 |
BUPRENORPHINE HYDROCHLORIDE |
TITAN PHARMS |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #205022 |
SUPPL-2 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE ANDA #205022 |
SUPPL-3 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
LANNETT CO INC |
Labeling |
Approval |
02/01/2018 |
BUNAVAIL NDA #205637 |
SUPPL-16 |
BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE |
BDSI |
Labeling |
Approval |
02/01/2018 |
AVYCAZ NDA #206494 |
SUPPL-4 |
AVIBACTAM SODIUM; CEFTAZIDIME |
ALLERGAN |
Efficacy |
Approval |
02/01/2018 |
BUPRENORPHINE HYDROCHLORIDE ANDA #207276 |
SUPPL-3 |
BUPRENORPHINE HYDROCHLORIDE |
RHODES PHARMS |
Labeling |
Approval |
02/01/2018 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #207515 |
ORIG-1 |
METHYLPHENIDATE HYDROCHLORIDE |
AMNEAL PHARMS |
|
Approval |
02/01/2018 |
OCALIVA NDA #207999 |
SUPPL-3 |
OBETICHOLIC ACID |
INTERCEPT PHARMS INC |
Labeling |
Approval |
02/01/2018 |
NIACIN ANDA #209236 |
ORIG-1 |
NIACIN |
AUROBINDO PHARMA LTD |
|
Approval |
02/02/2018 |
FERAHEME NDA #022180 |
SUPPL-9 |
FERUMOXYTOL |
COVIS |
Efficacy |
Approval |
02/02/2018 |
XOFIGO NDA #203971 |
SUPPL-12 |
RADIUM RA-223 DICHLORIDE |
BAYER HLTHCARE |
Labeling |
Approval |
02/02/2018 |
ZYDELIG NDA #205858 |
SUPPL-11 |
IDELALISIB |
GILEAD SCIENCES INC |
Labeling |
Approval |
02/02/2018 |
PRASUGREL ANDA #205987 |
ORIG-1 |
PRASUGREL HYDROCHLORIDE |
ACCORD HLTHCARE |
|
Approval |
02/02/2018 |
OXYMORPHONE HYDROCHLORIDE ANDA #210175 |
ORIG-1 |
OXYMORPHONE HYDROCHLORIDE |
ASCENT PHARMS INC |
|
Approval |
02/05/2018 |
PEDIAPRED NDA #019157 |
SUPPL-21 |
PREDNISOLONE SODIUM PHOSPHATE |
SETON PHARM |
Labeling |
Approval |
02/05/2018 |
SYMFI LO NDA #208255 |
ORIG-1 |
EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
MYLAN |
Type 3 - New Dosage Form |
Approval |
02/05/2018 |
TYMLOS NDA #208743 |
SUPPL-1 |
ABALOPARATIDE |
RADIUS |
Labeling |
Approval |
02/06/2018 |
SODIUM IODIDE I 131 NDA #016515 |
SUPPL-16 |
SODIUM IODIDE I-131 |
CURIUM |
Labeling |
Approval |
02/06/2018 |
SODIUM IODIDE I 131 NDA #016517 |
SUPPL-16 |
SODIUM IODIDE I-131 |
CURIUM |
Labeling |
Approval |
02/06/2018 |
CLARINEX-D 12 HOUR NDA #021313 |
SUPPL-9 |
DESLORATADINE; PSEUDOEPHEDRINE SULFATE |
ORGANON LLC |
Labeling |
Approval |
02/06/2018 |
ULORIC NDA #021856 |
SUPPL-12 |
FEBUXOSTAT |
TAKEDA PHARMS USA |
Labeling |
Approval |
02/06/2018 |
PRISTIQ NDA #021992 |
SUPPL-42 |
DESVENLAFAXINE SUCCINATE |
PF PRISM CV |
Efficacy |
Approval |
02/06/2018 |
METOPROLOL SUCCINATE ANDA #204106 |
ORIG-1 |
METOPROLOL SUCCINATE |
NOVAST LABS |
|
Approval |
02/06/2018 |
ZYDELIG NDA #205858 |
SUPPL-10 |
IDELALISIB |
GILEAD SCIENCES INC |
REMS |
Approval |
02/06/2018 |
IBRANCE NDA #207103 |
SUPPL-7 |
PALBOCICLIB |
PFIZER |
Efficacy |
Approval |
02/06/2018 |
LYNPARZA NDA #208558 |
SUPPL-2 |
OLAPARIB |
ASTRAZENECA |
Labeling |
Approval |
02/06/2018 |
INGENOL MEBUTATE ANDA #209086 |
ORIG-1 |
INGENOL MEBUTATE |
ACTAVIS LABS |
|
Tentative Approval |
02/06/2018 |
BETAMETHASONE DIPROPIONATE ANDA #209896 |
ORIG-1 |
BETAMETHASONE DIPROPIONATE |
HIKMA |
|
Approval |
02/07/2018 |
DORYX NDA #050582 |
SUPPL-30 |
DOXYCYCLINE HYCLATE |
MAYNE PHARMA |
Labeling |
Approval |
02/07/2018 |
DORYX NDA #050795 |
SUPPL-26 |
DOXYCYCLINE HYCLATE |
MAYNE PHARMA |
Labeling |
Approval |
02/07/2018 |
DORYX MPC NDA #050795 |
SUPPL-26 |
DOXYCYCLINE HYCLATE |
MAYNE PHARMA |
Labeling |
Approval |
02/07/2018 |
ACETAMINOPHEN AND CODEINE PHOSPHATE ANDA #087006 |
SUPPL-32 |
ACETAMINOPHEN; CODEINE PHOSPHATE |
WOCKHARDT BIO AG |
Labeling |
Approval |
02/07/2018 |
ZYTIGA NDA #202379 |
SUPPL-24 |
ABIRATERONE ACETATE |
JANSSEN BIOTECH |
Efficacy |
Approval |
02/07/2018 |
XALKORI NDA #202570 |
SUPPL-23 |
CRIZOTINIB |
PF PRISM CV |
Labeling |
Approval |
02/07/2018 |
XALKORI NDA #202570 |
SUPPL-24 |
CRIZOTINIB |
PF PRISM CV |
Labeling |
Approval |
02/07/2018 |
TRIENTINE HYDROCHLORIDE ANDA #207567 |
ORIG-1 |
TRIENTINE HYDROCHLORIDE |
WATSON LABS TEVA |
|
Approval |
02/07/2018 |
BIKTARVY NDA #210251 |
ORIG-1 |
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE |
GILEAD SCIENCES INC |
Type 1 - New Molecular Entity and Type 4 - New Combination |
Approval |
02/07/2018 |
AMANTADINE HYDROCHLORIDE ANDA #210403 |
ORIG-1 |
AMANTADINE HYDROCHLORIDE |
JUBILANT GENERICS |
|
Approval |
02/08/2018 |
TOTECT NDA #022025 |
SUPPL-16 |
DEXRAZOXANE HYDROCHLORIDE |
CLINIGEN |
Labeling |
Approval |
02/08/2018 |
YERVOY BLA #125377 |
SUPPL-93 |
IPILIMUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
02/08/2018 |
RADIOGENIX SYSTEM NDA #202158 |
ORIG-1 |
TECHNETIUM TC-99M SODIUM PERTECHNETATE GENERATOR |
NORTHSTAR MEDICAL |
Type 5 - New Formulation or New Manufacturer |
Approval |
02/08/2018 |
XARELTO NDA #202439 |
SUPPL-24 |
RIVAROXABAN |
JANSSEN PHARMS |
Labeling |
Approval |
02/08/2018 |
EXONDYS 51 NDA #206488 |
SUPPL-6 |
ETEPLIRSEN |
SAREPTA THERAPS INC |
Labeling |
Approval |
02/08/2018 |
CLINDAMYCIN PHOSPHATE ANDA #209846 |
ORIG-1 |
CLINDAMYCIN PHOSPHATE |
CHARTWELL RX |
|
Approval |
02/09/2018 |
CELESTONE SOLUSPAN NDA #014602 |
SUPPL-61 |
BETAMETHASONE ACETATE; BETAMETHASONE SODIUM PHOSPHATE |
ORGANON |
Labeling |
Approval |
02/09/2018 |
KINEVAC NDA #017697 |
SUPPL-31 |
SINCALIDE |
BRACCO |
Labeling |
Approval |
02/09/2018 |
BACTRIM NDA #018374 |
SUPPL-26 |
SULFAMETHOXAZOLE; TRIMETHOPRIM |
SUN PHARM INDS INC |
Labeling |
Approval |
02/09/2018 |
JANUVIA NDA #021995 |
SUPPL-42 |
SITAGLIPTIN PHOSPHATE |
MERCK SHARP DOHME |
Labeling |
Approval |
02/09/2018 |
JANUMET NDA #022044 |
SUPPL-43 |
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
MSD SUB MERCK |
Labeling |
Approval |
02/09/2018 |
BEPREVE NDA #022288 |
SUPPL-8 |
BEPOTASTINE BESILATE |
BAUSCH AND LOMB INC |
Labeling |
Approval |
02/09/2018 |
SIMPONI BLA #125289 |
SUPPL-141 |
GOLIMUMAB |
CENTOCOR ORTHO BIOTECH INC |
|
Approval |
02/09/2018 |
SIMPONI ARIA BLA #125433 |
SUPPL-24 |
GOLIMUMAB |
JANSSEN BIOTECH |
|
Approval |
02/09/2018 |
ELIQUIS NDA #202155 |
SUPPL-18 |
APIXABAN |
BRISTOL MYERS SQUIBB |
Labeling |
Approval |
02/09/2018 |
JANUMET XR NDA #202270 |
SUPPL-18 |
METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE |
MSD SUB MERCK |
Labeling |
Approval |
02/09/2018 |
REXULTI NDA #205422 |
SUPPL-3 |
BREXPIPRAZOLE |
OTSUKA |
Labeling |
Approval |
02/09/2018 |
DEXYCU KIT NDA #208912 |
ORIG-1 |
DEXAMETHASONE |
EYEPOINT PHARMS |
Type 5 - New Formulation or New Manufacturer |
Approval |
02/09/2018 |
FENOFIBRATE ANDA #209951 |
ORIG-1 |
FENOFIBRATE |
AMNEAL |
|
Approval |
02/09/2018 |
MEMANTINE HYDROCHLORIDE ANDA #209955 |
ORIG-1 |
MEMANTINE HYDROCHLORIDE |
APOTEX |
|
Approval |
02/09/2018 |
DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE NDA #210237 |
ORIG-1 |
DOLUTEGRAVIR;EMTRICITABINE;TENOFOVIR ALAFENAMIDE |
MYLAN LABS |
Type 4 - New Combination |
Tentative Approval |
02/09/2018 |
OXYCODONE AND ACETAMINOPHEN ANDA #210644 |
ORIG-1 |
ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE |
ABHAI LLC |
|
Approval |
02/12/2018 |
LOMOTIL NDA #012462 |
SUPPL-48 |
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE |
PFIZER |
Labeling |
Approval |
02/12/2018 |
NUVARING NDA #021187 |
SUPPL-31 |
ETHINYL ESTRADIOL; ETONOGESTREL |
ORGANON USA ORGANON |
Labeling |
Approval |
02/12/2018 |
GLATOPA ANDA #206921 |
ORIG-1 |
GLATIRAMER ACETATE |
SANDOZ |
|
Approval |
02/12/2018 |
SYMDEKO (COPACKAGED) NDA #210491 |
ORIG-1 |
IVACAFTOR; IVACAFTOR, TEZACAFTOR |
VERTEX PHARMS INC |
Type 1 - New Molecular Entity and Type 4 - New Combination |
Approval |
02/13/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077535 |
SUPPL-15 |
ONDANSETRON HYDROCHLORIDE |
GLENMARK PHARMS LTD |
Labeling |
Approval |
02/13/2018 |
ONDANSETRON ANDA #078152 |
SUPPL-14 |
ONDANSETRON |
GLENMARK PHARMS LTD |
Labeling |
Approval |
02/13/2018 |
OPDIVO BLA #125554 |
SUPPL-56 |
NIVOLUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
02/13/2018 |
DOXAZOSIN MESYLATE ANDA #205210 |
ORIG-1 |
DOXAZOSIN MESYLATE |
HERITAGE PHARMA |
|
Approval |
02/13/2018 |
BETAMETHASONE DIPROPIONATE ANDA #206389 |
ORIG-1 |
BETAMETHASONE DIPROPIONATE |
ENCUBE |
|
Approval |
02/13/2018 |
INTRAROSA NDA #208470 |
SUPPL-1 |
PRASTERONE |
MILLICENT |
Labeling |
Approval |
02/14/2018 |
PREVANTICS MAXI SWABSTICK NDA #021524 |
SUPPL-12 |
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL |
PROF DSPLS |
Efficacy |
Approval |
02/14/2018 |
PREVANTICS SWAB NDA #021524 |
SUPPL-12 |
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL |
PROF DSPLS |
Efficacy |
Approval |
02/14/2018 |
PREVANTICS SWABSTICK NDA #021524 |
SUPPL-12 |
CHLORHEXIDINE GLUCONATE; ISOPROPYL ALCOHOL |
PROF DSPLS |
Efficacy |
Approval |
02/14/2018 |
ERLEADA NDA #210951 |
ORIG-1 |
APALUTAMIDE |
JANSSEN BIOTECH |
Type 1 - New Molecular Entity |
Approval |
02/15/2018 |
NAROPIN NDA #020533 |
SUPPL-34 |
ROPIVACAINE HYDROCHLORIDE |
FRESENIUS KABI USA |
|
Approval |
02/15/2018 |
CIALIS NDA #021368 |
SUPPL-30 |
TADALAFIL |
LILLY |
Efficacy |
Approval |
02/15/2018 |
CHILDREN'S CLARITIN NDA #021891 |
SUPPL-26 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/15/2018 |
CLARITIN NDA #021891 |
SUPPL-26 |
LORATADINE |
BAYER HEALTHCARE LLC |
Labeling |
Approval |
02/15/2018 |
CYSVIEW KIT NDA #022555 |
SUPPL-5 |
HEXAMINOLEVULINATE HYDROCHLORIDE |
PHOTOCURE ASA |
Efficacy |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062719 |
SUPPL-8 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062719 |
SUPPL-9 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062719 |
SUPPL-10 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062772 |
SUPPL-13 |
AMPICILLIN SODIUM |
HQ SPECLT PHARMA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062797 |
SUPPL-6 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062797 |
SUPPL-7 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #062797 |
SUPPL-8 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #065493 |
SUPPL-4 |
AMPICILLIN SODIUM |
EUGIA PHARMA SPECLTS |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #065493 |
SUPPL-7 |
AMPICILLIN SODIUM |
EUGIA PHARMA SPECLTS |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #090581 |
SUPPL-2 |
AMPICILLIN SODIUM |
SAGENT PHARMS INC |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #090583 |
SUPPL-1 |
AMPICILLIN SODIUM |
SAGENT PHARMS INC |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #090583 |
SUPPL-2 |
AMPICILLIN SODIUM |
SAGENT PHARMS INC |
Labeling |
Approval |
02/15/2018 |
OPDIVO BLA #125554 |
SUPPL-44 |
NIVOLUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
02/15/2018 |
OPDIVO BLA #125554 |
SUPPL-45 |
NIVOLUMAB |
BRISTOL MYERS SQUIBB |
|
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #201404 |
SUPPL-1 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #201404 |
SUPPL-2 |
AMPICILLIN SODIUM |
ISTITUTO BIO ITA SPA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #202198 |
SUPPL-1 |
AMPICILLIN SODIUM |
STERISCIENCE |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #202198 |
SUPPL-2 |
AMPICILLIN SODIUM |
STERISCIENCE |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #202198 |
SUPPL-4 |
AMPICILLIN SODIUM |
STERISCIENCE |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #202864 |
SUPPL-1 |
AMPICILLIN SODIUM |
HOSPIRA |
Labeling |
Approval |
02/15/2018 |
AMPICILLIN SODIUM ANDA #202865 |
SUPPL-1 |
AMPICILLIN SODIUM |
HOSPIRA |
Labeling |
Approval |
02/15/2018 |
SUMATRIPTAN AND NAPROXEN SODIUM ANDA #207457 |
ORIG-1 |
NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE |
AUROBINDO PHARMA LTD |
|
Approval |
02/15/2018 |
NYSTATIN AND TRIAMCINOLONE ACETONIDE ANDA #209990 |
ORIG-1 |
NYSTATIN; TRIAMCINOLONE ACETONIDE |
AMNEAL |
|
Approval |
02/16/2018 |
ISOVUE-200 NDA #020327 |
SUPPL-14 |
IOPAMIDOL |
BRACCO |
Labeling |
Approval |
02/16/2018 |
ISOVUE-250 NDA #020327 |
SUPPL-14 |
IOPAMIDOL |
BRACCO |
Labeling |
Approval |
02/16/2018 |
ISOVUE-300 NDA #020327 |
SUPPL-14 |
IOPAMIDOL |
BRACCO |
Labeling |
Approval |
02/16/2018 |
ISOVUE-370 NDA #020327 |
SUPPL-14 |
IOPAMIDOL |
BRACCO |
Labeling |
Approval |
02/16/2018 |
EXJADE NDA #021882 |
SUPPL-26 |
DEFERASIROX |
NOVARTIS |
Labeling |
Approval |
02/16/2018 |
VALACYCLOVIR HYDROCHLORIDE ANDA #076588 |
SUPPL-16 |
VALACYCLOVIR HYDROCHLORIDE |
SUN PHARM INDS LTD |
Manufacturing (CMC) |
Approval |
02/16/2018 |
STELARA BLA #125261 |
SUPPL-141 |
USTEKINUMAB |
CENTOCOR ORTHO BIOTECH INC |
|
Approval |
02/16/2018 |
ENTYVIO BLA #125476 |
SUPPL-22 |
VEDOLIZUMAB |
TAKEDA PHARMS USA |
|
Approval |
02/16/2018 |
ADENOSINE ANDA #206778 |
ORIG-1 |
ADENOSINE |
GLAND PHARMA LTD |
|
Approval |
02/16/2018 |
JADENU NDA #206910 |
SUPPL-7 |
DEFERASIROX |
NOVARTIS PHARMS CORP |
Labeling |
Approval |
02/16/2018 |
JADENU SPRINKLE NDA #207968 |
SUPPL-2 |
DEFERASIROX |
NOVARTIS |
Labeling |
Approval |
02/16/2018 |
IBUPROFEN ANDA #209178 |
ORIG-1 |
IBUPROFEN |
AUROBINDO PHARMA LTD |
|
Approval |
02/16/2018 |
OSMOLEX ER NDA #209410 |
ORIG-1 |
AMANTADINE HYDROCHLORIDE |
ADAMAS OPERATIONS |
Type 3 - New Dosage Form |
Approval |
02/16/2018 |
ELTROMBOPAG ANDA #209938 |
ORIG-1 |
ELTROMBOPAG |
TEVA PHARMS USA INC |
|
Tentative Approval |
02/16/2018 |
IMBRUVICA NDA #210563 |
ORIG-1 |
IBRUTINIB |
PHARMACYCLICS LLC |
Type 3 - New Dosage Form |
Approval |
02/16/2018 |
IMBRUVICA NDA #210563 |
ORIG-2 |
IBRUTINIB |
PHARMACYCLICS LLC |
Efficacy |
Approval |
02/16/2018 |
IMFINZI BLA #761069 |
SUPPL-2 |
DURVALUMAB |
ASTRAZENECA UK LTD |
|
Approval |
02/20/2018 |
LEVONORGESTREL ANDA #202246 |
SUPPL-4 |
LEVONORGESTREL |
ALVOGEN |
Labeling |
Approval |
02/20/2018 |
LUZU NDA #204153 |
SUPPL-4 |
LULICONAZOLE |
BAUSCH |
Efficacy |
Approval |
02/20/2018 |
LUZU NDA #204153 |
SUPPL-5 |
LULICONAZOLE |
BAUSCH |
Efficacy |
Approval |
02/20/2018 |
PURIXAN NDA #205919 |
SUPPL-3 |
MERCAPTOPURINE |
NOVA LABS LTD |
Labeling |
Approval |
02/20/2018 |
OSELTAMIVIR PHOSPHATE ANDA #208347 |
ORIG-1 |
OSELTAMIVIR PHOSPHATE |
LUPIN |
|
Approval |
02/21/2018 |
VOLTAREN ARTHRITIS PAIN NDA #022122 |
SUPPL-11 |
DICLOFENAC SODIUM |
HALEON US HOLDINGS |
Labeling |
Approval |
02/21/2018 |
AMPICILLIN SODIUM ANDA #061395 |
SUPPL-43 |
AMPICILLIN SODIUM |
SANDOZ |
Labeling |
Approval |
02/21/2018 |
AMPICILLIN SODIUM ANDA #063142 |
SUPPL-13 |
AMPICILLIN SODIUM |
HQ SPECLT PHARMA |
Labeling |
Approval |
02/21/2018 |
AMPICILLIN SODIUM ANDA #063142 |
SUPPL-15 |
AMPICILLIN SODIUM |
HQ SPECLT PHARMA |
Labeling |
Approval |
02/21/2018 |
AMPICILLIN SODIUM ANDA #065499 |
SUPPL-4 |
AMPICILLIN SODIUM |
EUGIA PHARMA SPECLTS |
Labeling |
Approval |
02/21/2018 |
AMPICILLIN SODIUM ANDA #065499 |
SUPPL-7 |
AMPICILLIN SODIUM |
EUGIA PHARMA SPECLTS |
Labeling |
Approval |
02/21/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077545 |
SUPPL-11 |
ONDANSETRON HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
02/21/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077545 |
SUPPL-12 |
ONDANSETRON HYDROCHLORIDE |
HIKMA INTL PHARMS |
Labeling |
Approval |
02/21/2018 |
ACETAMINOPHEN AND CODEINE PHOSPHATE ANDA #089450 |
SUPPL-23 |
ACETAMINOPHEN; CODEINE PHOSPHATE |
CHARTWELL |
Labeling |
Approval |
02/21/2018 |
ACETAMINOPHEN AND CODEINE PHOSPHATE ANDA #091238 |
SUPPL-13 |
ACETAMINOPHEN; CODEINE PHOSPHATE |
CHARTWELL MOLECULAR |
Labeling |
Approval |
02/21/2018 |
ACETAMINOPHEN AND CODEINE PHOSPHATE ANDA #091238 |
SUPPL-14 |
ACETAMINOPHEN; CODEINE PHOSPHATE |
CHARTWELL MOLECULAR |
Labeling |
Approval |
02/21/2018 |
VANCOMYCIN HYDROCHLORIDE IN PLASTIC CONTAINER ANDA #091532 |
SUPPL-1 |
VANCOMYCIN HYDROCHLORIDE |
SAMSON MEDCL |
Labeling |
Approval |
02/21/2018 |
PIROXICAM ANDA #208991 |
ORIG-1 |
PIROXICAM |
BRECKENRIDGE |
|
Approval |
02/22/2018 |
SOMATULINE DEPOT NDA #022074 |
SUPPL-18 |
LANREOTIDE ACETATE |
IPSEN PHARMA |
Labeling |
Approval |
02/22/2018 |
RANITIDINE HYDROCHLORIDE ANDA #209161 |
ORIG-1 |
RANITIDINE HYDROCHLORIDE |
STRIDES PHARMA |
|
Approval |
02/22/2018 |
LUSDUNA NDA #209764 |
ORIG-1 |
INSULIN GLARGINE |
MERCK SHARP DOHME |
Type 5 - New Formulation or New Manufacturer |
Tentative Approval |
02/23/2018 |
NORDITROPIN BLA #021148 |
SUPPL-37 |
SOMATROPIN |
NOVO NORDISK INC |
|
Approval |
02/23/2018 |
NORDITROPIN BLA #021148 |
SUPPL-38 |
SOMATROPIN |
NOVO NORDISK INC |
|
Approval |
02/23/2018 |
NORDITROPIN FLEXPRO BLA #021148 |
SUPPL-37 |
SOMATROPIN |
NOVO NORDISK INC |
|
Approval |
02/23/2018 |
NORDITROPIN FLEXPRO BLA #021148 |
SUPPL-38 |
SOMATROPIN |
NOVO NORDISK INC |
|
Approval |
02/23/2018 |
NORDITROPIN NORDIFLEX BLA #021148 |
SUPPL-37 |
SOMATROPIN |
NOVO NORDISK INC |
|
Approval |
02/23/2018 |
NORDITROPIN NORDIFLEX BLA #021148 |
SUPPL-38 |
SOMATROPIN |
NOVO NORDISK INC |
|
Approval |
02/23/2018 |
CUVPOSA NDA #022571 |
SUPPL-8 |
GLYCOPYRROLATE |
MERZ PHARMS |
Labeling |
Approval |
02/23/2018 |
ATOMOXETINE HYDROCHLORIDE ANDA #090609 |
ORIG-1 |
ATOMOXETINE HYDROCHLORIDE |
DR REDDYS |
|
Approval |
02/23/2018 |
EFAVIRENZ NDA #205389 |
ORIG-1 |
EFAVIRENZ |
MICRO LABS LTD INDIA |
Type 5 - New Formulation or New Manufacturer |
Tentative Approval |
02/23/2018 |
ALOSETRON HYDROCHLORIDE ANDA #206113 |
ORIG-1 |
ALOSETRON HYDROCHLORIDE |
PAR PHARM INC |
|
Approval |
02/23/2018 |
APADAZ NDA #208653 |
ORIG-1 |
ACETAMINOPHEN; BENZHYDROCODONE HYDROCHLORIDE |
ZEVRA THERAP |
Type 4 - New Combination |
Approval |
02/23/2018 |
OSELTAMIVIR PHOSPHATE ANDA #209438 |
ORIG-1 |
OSELTAMIVIR PHOSPHATE |
HETERO LABS LTD III |
|
Approval |
02/26/2018 |
ADVIL ALLERGY AND CONGESTION RELIEF NDA #022113 |
SUPPL-3 |
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE |
HALEON US HOLDINGS |
Labeling |
Approval |
02/26/2018 |
ADVIL ALLERGY AND CONGESTION RELIEF NDA #022113 |
SUPPL-4 |
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE |
HALEON US HOLDINGS |
Labeling |
Approval |
02/26/2018 |
ADVIL MULTI-SYMPTOM COLD & FLU NDA #022113 |
SUPPL-3 |
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE |
HALEON US HOLDINGS |
Labeling |
Approval |
02/26/2018 |
ADVIL MULTI-SYMPTOM COLD & FLU NDA #022113 |
SUPPL-4 |
CHLORPHENIRAMINE MALEATE; IBUPROFEN; PHENYLEPHRINE HYDROCHLORIDE |
HALEON US HOLDINGS |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #076183 |
SUPPL-7 |
ONDANSETRON HYDROCHLORIDE |
DR REDDYS LABS LTD |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #076183 |
SUPPL-9 |
ONDANSETRON HYDROCHLORIDE |
DR REDDYS LABS LTD |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #076183 |
SUPPL-12 |
ONDANSETRON HYDROCHLORIDE |
DR REDDYS LABS LTD |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077303 |
SUPPL-2 |
ONDANSETRON HYDROCHLORIDE |
CHARTWELL MOLECULES |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077306 |
SUPPL-10 |
ONDANSETRON HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077306 |
SUPPL-11 |
ONDANSETRON HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON HYDROCHLORIDE ANDA #077306 |
SUPPL-12 |
ONDANSETRON HYDROCHLORIDE |
APOTEX |
Labeling |
Approval |
02/26/2018 |
ONDANSETRON ANDA #077406 |
SUPPL-6 |
ONDANSETRON |
CHARTWELL MOLECULES |
Labeling |
Approval |
02/26/2018 |
TRAMADOL HYDROCHLORIDE AND ACETAMINOPHEN ANDA #077858 |
SUPPL-6 |
ACETAMINOPHEN; TRAMADOL HYDROCHLORIDE |
RISING |
Labeling |
Approval |
02/26/2018 |
METHYLPHENIDATE HYDROCHLORIDE ANDA #200886 |
ORIG-1 |
METHYLPHENIDATE HYDROCHLORIDE |
DR REDDYS LABS SA |
|
Approval |
02/26/2018 |
DESFLURANE ANDA #208234 |
ORIG-1 |
DESFLURANE |
SHANGHAI HENGRUI |
|
Approval |
02/26/2018 |
VERZENIO NDA #208855 |
ORIG-1 |
ABEMACICLIB |
ELI LILLY AND CO |
Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval |
Approval |
02/26/2018 |
TENOFOVIR DISOPROXIL FUMARATE ANDA #209550 |
ORIG-1 |
TENOFOVIR DISOPROXIL FUMARATE |
CASI PHARMS INC |
|
Approval |
02/27/2018 |
DEXMEDETOMIDINE HYDROCHLORIDE ANDA #206798 |
ORIG-1 |
DEXMEDETOMIDINE HYDROCHLORIDE |
ZYDUS PHARMS |
|
Approval |
02/27/2018 |
LO-ZUMANDIMINE ANDA #209632 |
ORIG-1 |
DROSPIRENONE; ETHINYL ESTRADIOL |
AUROBINDO PHARMA LTD |
|
Approval |
02/27/2018 |
OSELTAMIVIR PHOSPHATE ANDA #210186 |
ORIG-1 |
OSELTAMIVIR PHOSPHATE |
AMNEAL PHARMS NY |
|
Approval |
02/28/2018 |
CYTOTEC NDA #019268 |
SUPPL-51 |
MISOPROSTOL |
PFIZER |
Labeling |
Approval |
02/28/2018 |
ZOCOR NDA #019766 |
SUPPL-98 |
SIMVASTATIN |
ORGANON |
Labeling |
Approval |
02/28/2018 |
ALTOPREV NDA #021316 |
SUPPL-35 |
LOVASTATIN |
COVIS |
Labeling |
Approval |
02/28/2018 |
CLARINEX D 24 HOUR NDA #021605 |
SUPPL-15 |
DESLORATADINE; PSEUDOEPHEDRINE SULFATE |
ORGANON |
Labeling |
Approval |
02/28/2018 |
VYTORIN NDA #021687 |
SUPPL-60 |
EZETIMIBE; SIMVASTATIN |
ORGANON |
Labeling |
Approval |
02/28/2018 |
CIMDUO NDA #022141 |
ORIG-1 |
LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE |
MYLAN LABS LTD |
Type 4 - New Combination |
Approval |
02/28/2018 |
ACTIVASE BLA #103172 |
SUPPL-5259 |
ALTEPLASE |
GENENTECH |
|
Approval |
02/28/2018 |
ACTIVASE BLA #103172 |
SUPPL-5260 |
ALTEPLASE |
GENENTECH |
|
Approval |
02/28/2018 |
CATHFLO ACTIVASE BLA #103172 |
SUPPL-5259 |
ALTEPLASE |
GENENTECH |
|
Approval |
02/28/2018 |
CATHFLO ACTIVASE BLA #103172 |
SUPPL-5260 |
ALTEPLASE |
GENENTECH |
|
Approval |
02/28/2018 |
TNKASE BLA #103909 |
SUPPL-5187 |
TENECTEPLASE |
GENENTECH |
|
Approval |
02/28/2018 |
SOLIRIS BLA #125166 |
SUPPL-426 |
ECULIZUMAB |
ALEXION PHARM |
|
Approval |
02/28/2018 |
MOVANTIK NDA #204760 |
SUPPL-7 |
NALOXEGOL OXALATE |
VALINOR |
Labeling |
Approval |
02/28/2018 |
ESOMEPRAZOLE MAGNESIUM ANDA #207079 |
ORIG-1 |
ESOMEPRAZOLE MAGNESIUM |
ACTAVIS LABS FL INC |
|
Tentative Approval |
02/28/2018 |
ZTLIDO NDA #207962 |
ORIG-1 |
LIDOCAINE |
SCILEX PHARMS |
Type 5 - New Formulation or New Manufacturer |
Approval |
02/28/2018 |
OMEPRAZOLE NDA #209400 |
SUPPL-1 |
OMEPRAZOLE |
DEXCEL |
Labeling |
Approval |
02/28/2018 |
ESTRADIOL AND NORETHINDRONE ACETATE ANDA #210233 |
ORIG-1 |
ESTRADIOL; NORETHINDRONE ACETATE |
NAARI PTE LTD |
|
Approval |